Friday, July 10, 2026
🇺🇸 FDA

Intelligence · Clinical pipeline

Phase III Pipeline Programs

Late-stage pivotal and registrational clinical programs nearing regulatory submission.

Programs 5,427
Sponsors 1,771
Drugs 4,798

Quick answer

NovaPharmaNews tracks 5,427 phase iii pharmaceutical pipeline programs from ClinicalTrials.gov. Late-stage pivotal and registrational clinical programs nearing regulatory submission.

Top sponsors

Pipeline programs

Page 102 of 114

  1. Viltolarsen

    Lacuna Pharma Pty Ltd

    Duchenne Muscular Dystrophy (DMD)

    phase 3 small molecule active

    1 trial

  2. Vincristine Sulfate Liposome

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Adult Acute Lymphoblastic Leukemia

    phase 3 small molecule active

    1 trial

  3. Vinflunine

    Bristol-Myers Squibb

    Stomach Cancer

    phase 3 small molecule terminated

    1 trial

  4. Virtual Reality Exposure Therapy - Dynamic

    Camp4 Therapeutics Corp

    Post Traumatic Stress Disorder

    phase 3 other active

    1 trial

  5. Virulizin®

    Aptose Biosciences

    Pancreatic Cancer

    phase 3 small molecule completed

    1 trial

  6. Visilizumab

    The First People's Hospital of Lianyungang

    Immunotherapy

    phase 3 small molecule active

    1 trial

  7. Vitamin A

    United Therapeutics Europe Ltd

    Sepsis

    phase 3 other completed

    1 trial

  8. Vitamin D3

    Hospital Authority, Hong Kong

    Lupus Erythematosus, Systemic

    phase 3 small molecule completed

    1 trial

  9. Vivitrol

    BRIGHT MINDS BIOSCIENCES INC.

    Opioid Dependence

    phase 3 small molecule completed

    2 trials

  10. Vivitrol

    BRIGHT MINDS BIOSCIENCES INC.

    Opiate Dependence

    phase 3 small molecule completed

    1 trial

  11. Vivitrol

    BRIGHT MINDS BIOSCIENCES INC.

    Opioid-use Disorder

    phase 3 small molecule completed

    1 trial

  12. Voclosporin

    Aurinia Pharmaceuticals

    Adolescent Lupus Nephritis

    phase 3 small molecule terminated

    2 trials

  13. Voclosporin

    Aurinia Pharmaceuticals

    Lupus Nephritis

    phase 3 small molecule completed

    3 trials

  14. Volanesorsen

    IONIS PHARMACEUTICALS INC

    Hypertriglyceridemia

    phase 3 small molecule completed

    1 trial

  15. Volanesorsen

    IONIS PHARMACEUTICALS INC

    Familial Chylomicronemia Syndrome

    phase 3 small molecule completed

    2 trials

  16. Volrustomig

    Arcus Biosciences

    Advanced Clear Cell Renal Cell Carcinoma

    phase 3 small molecule active

    1 trial

  17. Vonicog Alfa

    Takeda

    Von Willebrand Disease (VWD)

    phase 3 mab active

    1 trial

  18. Vonicog alfa

    Takeda

    Von Willebrand Disease

    phase 3 mab completed

    1 trial

  19. Vonoprazan

    Phathom Pharmaceuticals

    Non-Erosive Gastro-Esophageal Reflux Disease

    phase 3 small molecule completed

    2 trials

  20. Vonoprazan

    Phathom Pharmaceuticals

    Erosive Esophagitis

    phase 3 small molecule completed

    2 trials

  21. Vonoprazan

    Phathom Pharmaceuticals

    Helicobacter Pylori Infection

    phase 3 small molecule completed

    1 trial

  22. Vonoprazan

    Takeda

    Healthy Volunteers

    phase 3 small molecule completed

    1 trial

  23. Vonoprazan

    Takeda

    Helicobacter Pylori

    phase 3 small molecule completed

    1 trial

  24. Vortioxetine

    Takeda

    Major Depressive Disorder

    phase 3 small molecule completed

    9 trials

  25. Vortioxetine

    The University of Hong Kong

    Cannabis Use Disorder

    phase 3 small molecule completed

    1 trial

  26. Vortioxetine

    COGNITION THERAPEUTICS INC

    Major Depressive Disorder

    phase 3 small molecule completed

    1 trial

  27. Vortioxetine

    Takeda

    Generalized Anxiety Disorder

    phase 3 small molecule completed

    3 trials

  28. Vortioxetine

    Takeda

    TBI

    phase 3 small molecule terminated

    1 trial

  29. Vortioxetine

    Takeda

    Treatment Outcome

    phase 3 small molecule completed

    1 trial

  30. Vortioxetine

    Takeda

    Depressive Disorder, Major

    phase 3 small molecule completed

    5 trials

  31. Vortioxetine 10 mg/day

    Takeda

    Depressive Disorder, Major

    phase 3 small molecule completed

    2 trials

  32. Vortioxetine tablets

    Takeda

    Major Depressive Disorder

    phase 3 small molecule active

    1 trial

  33. Vosoritide

    BioMarin Pharmaceutical Australia Pty Ltd

    Hypochondroplasia

    phase 3 small molecule active

    3 trials

  34. Voucher-Based Reinforcement Therapy

    BRIGHT MINDS BIOSCIENCES INC.

    Substance-related Disorders

    phase 3 other completed

    1 trial

  35. Vutrisiran

    Alnylam Netherlands B.V.

    Transthyretin Amyloidosis (ATTR) With Cardiomyopathy

    phase 3 small molecule active

    2 trials

  36. Vyvanse (lisdexamfetamine dimesylate)

    Takeda

    ADHD

    phase 3 small molecule completed

    1 trial

  37. Vyvgart 1 000 mg solution for injection

    argenx

    Generalized Myasthenia Gravis

    phase 3 small molecule active

    1 trial

  38. Vyvgart 20 mg/mL concentrate for solution for infusion

    argenx

    Generalized Myasthenia Gravis (gMG)

    phase 3 small molecule active

    1 trial

  39. Vyvgart 20 mg/mL concentrate for solution for infusion

    argenx

    Generalized Myasthenia Gravis

    phase 3 small molecule active

    1 trial

  40. Vyxeos

    Jazz Pharmaceuticals Ireland Limited

    Acute Myeloid Leukaemia

    phase 3 small molecule active

    1 trial

  41. WA40404

    Hoffmann-La Roche

    Primary progressive multiple sclerosis (PPMS)

    phase 3 small molecule active

    1 trial

  42. WA41937

    Hoffmann-La Roche

    Primary Membranous Nephropathy (pMN)

    phase 3 small molecule active

    1 trial

  43. WA43380

    Hoffmann-La Roche

    Childhood Idiopathic Nephrotic Syndrome

    phase 3 small molecule active

    1 trial

  44. WC45725

    Hoffmann-La Roche

    Obesity or Overweight Without Type 2 Diabetes

    phase 3 small molecule active

    1 trial

  45. WC45726

    Hoffmann-La Roche

    Obesity or Overweight and Type 2 Diabetes

    phase 3 small molecule active

    1 trial

  46. WN42086

    Hoffmann-La Roche

    Relapsing-Remitting Multiple Sclerosis

    phase 3 small molecule active

    1 trial

  47. WN43174

    Hoffmann-La Roche

    NMDAR or LGI1 mediated autoimmune Encephalitis

    phase 3 other active

    1 trial

  48. WN43194

    Hoffmann-La Roche

    Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD)

    phase 3 other active

    1 trial

Frequently asked questions

How many Phase III pipeline programs are in the directory?

5,427 published programs match this development stage in our ClinicalTrials.gov index.

What defines this pipeline stage?

Phase and status reflect ClinicalTrials.gov registry fields at last sync. See our clinical trial phases reference for methodology.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.